CDK9-IN-38
CDK9-IN-38 (compound 14) is a CDK9 inhibitor with IC50 values of 1.2 nM and 3.3 nM for CDK9 wild-type and L156F mutant, respectively. CDK9-IN-38 inhibits tumor growth in vivo and in vitro[1].
Product Specifications
CAS Number
2773402-44-9
UNSPSC
12352005
Target
CDK
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
O=C1NCC(C)(C)C2=CC(C3=NC(NC4=CC=CC(CS(N)(=O)=O)=C4)=NC=C3)=CC=C21
Molecular Formula
C22H23N5O3S
Molecular Weight
437.51
References & Citations
[1]Shi C, et al. Discovery of a Novel Dihydroisoquinolinone Derivative as a Potent CDK9 Inhibitor Capable of Overcoming L156F Mutant for the Treatment of Hematologic Malignancies. J Med Chem. 2025 Apr 24;68 (8) :8106-8123.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC427870 20 µg
Sphingomyelin Synthase 2 (SGMS2) (NM_001136258) Human Over-expression Lysate
Sign In for Pricing
View Details 
LC431817 20 µg
AFAF (EQTN) (NM_001161585) Human Over-expression Lysate
Sign In for Pricing
View Details 
![RING1 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI11G7]](https://cdn.genprice.uk/products/937/6868c3f4994c49e6dc4028c3/imageurl/ta809296am.webp)
TA809296AM 100 µL
RING1 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI11G7]
Sign In for Pricing
View Details